Application 219237

Type
ANDA
Sponsor
GLAND

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EPOPROSTENOL SODIUMEPOPROSTENOL SODIUMINJECTABLE;INJECTIONEQ 0.5MG BASE/VIALNoNo
002EPOPROSTENOL SODIUMEPOPROSTENOL SODIUMINJECTABLE;INJECTIONEQ 1.5MG BASE/VIALNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219237-001EPOPROSTENOL SODIUMEPOPROSTENOL SODIUMEQ 0.5MG BASE/VIALINJECTABLE / INJECTIONAP22025-12-29
A219237-002EPOPROSTENOL SODIUMEPOPROSTENOL SODIUMEQ 1.5MG BASE/VIALINJECTABLE / INJECTIONAP22025-12-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A219237-001AP2
A219237-002AP2

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A219237-001EPOPROSTENOL SODIUMEQ 0.5MG BASE/VIALINJECTABLE / INJECTIONAP22025-12-29caaa826d4ba7…
2026-08-18 06:07:402026-07A219237-002EPOPROSTENOL SODIUMEQ 1.5MG BASE/VIALINJECTABLE / INJECTIONAP22025-12-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219237-001EPOPROSTENOL SODIUMEQ 0.5MG BASE/VIALINJECTABLE / INJECTIONAP22025-12-29011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219237-002EPOPROSTENOL SODIUMEQ 1.5MG BASE/VIALINJECTABLE / INJECTIONAP22025-12-29011fe1cb6892…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219237-001EPOPROSTENOL SODIUMEQ 0.5MG BASE/VIALINJECTABLE / INJECTIONAP22025-12-29a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219237-002EPOPROSTENOL SODIUMEQ 1.5MG BASE/VIALINJECTABLE / INJECTIONAP22025-12-29a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A219237-001AP21caaa826d4ba7…
2026-08-18 06:07:402026-07A219237-002AP21caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219237-001AP21011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219237-002AP21011fe1cb6892…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219237-001AP21a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219237-002AP21a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EpoprostenolEPOPROSTENOLGland Pharma Limited47f64fcd-cbf7-457a-9548-661fb10ff7e02026-01-06Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219237
application number: ANDA219237